CDY - A Hair Raising Stock

[Flugenbear]

A name change is on the cards....

The Company proposes to change its name from “Cellmid Limited” to “Anagenics Limited” which more accurately reflects the current and proposed future operations of the Company, its scientific origins and corporate ethos. The change of name will take effect from when ASIC alters the details of the Company's registration.The word Anagenics is derived from the Greek “anagennitheis”, which means regenerate, regrow, grow. The first part of the word, anagen, describes the growth phase of the hair follicle, the key target for the Company’s FGF5 inhibitor hair technologies. The Company’s FGF5 inhibitor technology extends this ‘anagen’ or growth phase of the hair cycle, thereby the name Anagenics will honour the health and beauty tech origins of the Company. Further, the word also represents longevity, growth and regeneration as concepts which are all connected to wellness, youth, and beauty; these are the targeted indications for the Company’s current and future products and services. The word Anagenics is strongly descriptive of the Company’s objective to create an information and advice driven marketplace for scientifically validated health, wellness, and longevity brands.

[Minerbarejet]

https://7135c6e4-fccc-4e8a-a89e-1d1e...a9d849ba53.pdf

Above is a link to the newly established Roquefort investments who are very interested in taking midkine to a new level

by looking to purchase Lyramid from Provelmare who recently purchased Lyramid from Cellmid.

Given that Cellmid still retains the patents and Lyramid has a license to access those patents any indication of a plan of

attack should be of considerable interest.

According to the above link it looks as if there is some hope of developing a Covid 19 drug with midkine antibodies that

would alleviate cytokine storms, a devastating result of contracting Covid.

I would suggest that anyone contemplating not taking advantage of available vaccines read the above link for a

summary and the science behind this approach.

Especially pages 17 to 21

[Minerbarejet]

Cellmid is to change its name to Anagenics once the ASX approves it
The new code is hopefully AN1.
Voted in at todays AGM by what can only be described as an overwhelming mandate to do so.
99.5% for.